Cargando…

Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study

INTRODUCTION: Intensive care unit (ICU) patients often suffer from subcutaneous oedema, due to administration of large fluid volumes and the underlying pathophysiological condition. It is unknown whether the presence of subcutaneous oedema impairs the absorption of dalteparin, a low molecular weight...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rommers, Mirjam K, Van Der Lely, Netty, Egberts, Toine CG, van den Bemt, Patricia MLA
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550968/ https://www.ncbi.nlm.nih.gov/pubmed/16790078 http://dx.doi.org/10.1186/cc4952

Ejemplares similares

Anti-Xa activity after subcutaneous administration of dalteparin in intensive care unit patients with and without subcutaneous oedema
por: Rommers, M, et al.
Publicado: (2005)

A Case of Progressive Subcutaneous Œdema
por: Greig, D. M.
Publicado: (1916)

Effects of dalteparin on anti‐Xa activities cannot be predicted in critically ill COVID‐19 patients
por: van der Heijden, Charlotte D. C. C., et al.
Publicado: (2022)

Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey
por: Bekker, Charlotte, et al.
Publicado: (2019)

Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study
por: Leendertse, Anne J, et al.
Publicado: (2011)

The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patients
por: Karapinar-Çarkıt, Fatma, et al.
Publicado: (2010)

Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers
por: Gadiko, C., et al.
Publicado: (2013)

Whole-body MRI revealed generalized subcutaneous oedema in a patient with juvenile dermatomyositis
por: Fujita, Yuji, et al.
Publicado: (2023)

Association Between Workarounds and Medication Administration Errors in Bar Code-Assisted Medication Administration: Protocol of a Multicenter Study
por: van der Veen, Willem, et al.
Publicado: (2017)

Subcutaneous vaccine administration – an outmoded practice
por: Cook, Ian F.
Publicado: (2020)

Pyridoxine induced neuropathy by subcutaneous administration in dogs
por: Chung, Jin-Young, et al.
Publicado: (2008)

Minimization of administration route errors with subcutaneous rituximab
por: Liptrott, Sarah, et al.
Publicado: (2016)

Treatment of Phthisis by Subcutaneous Administration of Carbolic Acid
Publicado: (1886)

Does dalteparin PROTECT better than heparin?
por: Przybysz, Thomas, et al.
Publicado: (2011)

Subcutaneous Emphysema From Bronchocavitary Subcutaneous Fistula
por: Shankar, P. S.
Publicado: (2008)

Extensive subcutaneous emphysema treated with subcutaneous angiocatheters
por: Carleton, Lena, et al.
Publicado: (2023)

Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
por: Bittner, Beate, et al.
Publicado: (2018)

Ustekinumab pharmacokinetics after subcutaneous administration in swine model
por: Grabowski, Tomasz, et al.
Publicado: (2021)

Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
por: Epstein, Robert S
Publicado: (2021)

Lipodystrophy: Still an underdiagnosed complication of subcutaneous insulin administration
por: Barbosa, Mariana, et al.
Publicado: (2022)

Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study
por: den Broeder, Alfons A, et al.
Publicado: (2013)

Critically ill patients with edema and ascites may experience subtherapeutic anti-factor Xa levels following abdominal subcutaneous enoxaparin treatment
por: Tharanon, Vichapat, et al.
Publicado: (2022)

Management of venous thromboembolism in patients with cancer: role of dalteparin
por: Linkins, Lori-Ann
Publicado: (2008)

Dalteparin-sodium: Chest wall haematoma: case report
Publicado: (2022)

Management of extensive subcutaneous emphysema with a subcutaneous drain
por: O'Reilly, Peter, et al.
Publicado: (2013)

Subcutaneous Hematoma following Subcutaneous Emphysema: An Occult Association
por: Khandelwal, Ankur, et al.
Publicado: (2017)

On the Subcutaneous Injection of Blood, Infusion (Subcutaneous) and Intravenous Transfusion
por: Oehler,, et al.
Publicado: (1888)

A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY
por: Kim, Jwa Hoon, et al.
Publicado: (2022)

Subcutaneous Administration of Bortezomib: Strategies to Reduce Injection Site Reactions
por: Kurtin, Sandra, et al.
Publicado: (2012)

Toxicity Study of Streptococcus pneumoniae Vaccine Administrated Subcutaneously in Rats
por: Park, Sin Jeong, et al.
Publicado: (2011)

Subcutaneous Administration of Bortezomib: A Pilot Survey of Oncology Nurses
por: Martin, Jasmine R., et al.
Publicado: (2015)

Pharmacokinetics of Tildipirosin in Ewes after Intravenous, Intramuscular and Subcutaneous Administration
por: Galecio, Juan Sebastián, et al.
Publicado: (2020)

Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
por: Taylor, Douglas J., et al.
Publicado: (2022)

Use of dexmedetomidine repeated subcutaneous administration for balanced anaesthesia in horses
por: Rabbogliatti, Vanessa, et al.
Publicado: (2022)

Subcutaneous REGEN-COV antibody administration in a community pharmacy
por: Dougherty, Tyler S., et al.
Publicado: (2023)

Robenacoxib pharmacokinetics in sheep following oral, subcutaneous, and intravenous administration
por: Fadel, Charbel, et al.
Publicado: (2022)

Dermatologic adverse effect of subcutaneous furosemide administration in a cat
por: Mazzoldi, Chiara, et al.
Publicado: (2023)

A survey of subcutaneous blood flow in patients with SMID and subcutaneous ceftazidime administration using mentholated warm compresses in healthy subjects
por: Ebihara, Tsuyoshi, et al.
Publicado: (2016)

Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines
por: Minjon, Lenneke, et al.
Publicado: (2022)

Subcutaneous cysticercosis
por: Kumar, B. Siddhartha, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u7irmrbgb8uuad136aah7fchj3